# Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism

> **NCT02282150** · PHASE4 · UNKNOWN · sponsor: **Ulla Feldt-Rasmussen** · enrollment: 30 (estimated)

## Conditions studied

- Adrenal Insufficiency

## Interventions

- **DRUG:** Hydrocortisone
- **DRUG:** Plenadren

## Key facts

- **NCT ID:** NCT02282150
- **Lead sponsor:** Ulla Feldt-Rasmussen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2017-11
- **Final completion:** 2017-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02282150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02282150, "Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02282150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*